Cancer has long been seen as a non-curable illnesses, have no confidence in the treatment of cancer, and even some people simply give up treatment, in fact, modern medicine has made great advances in, for the cancer does not mean death, Herceptin targeted therapy drugs such as the emergence of targeted treatment is possible to cure a variety of cancers.
A study, HER2-positive breast cancer patients receiving doxorubicin and cyclophosphamide treatment, the combination of Herceptin and paclitaxel or paclitaxel alone for one year, the use of trastuzumab reduced the recurrence rate in patients 52%, and reduced mortality by 33%. In other words, the use of drug therapy for one year, HER2-positive breast cancer recurrence risk reduced by half, and mortality by one third. At the same time, breast cancer patients improved quality of life, can significantly reduce the surgical area to reduce the risk of treatment failure, and maximize survival of patients.
Herceptin treatment in breast cancer patients get so hot encouraging therapeutic effects is the first biological therapy for breast cancer targeted therapy, promote breast cancer treatment process, provide more effective treatment for patients choice.
Subscribe To
Posts
Comments
